Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC)-Reference-Cited by-同舟云学术

Surrogates of immunologic cell death (ICD) and chemoradiotherapy outcomes in head and neck squamous cell carcinoma (HNSCC)

Published:2019-07 Issue: Volume:94 Page:93-100
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Economopoulou Panagiota^ORCID,Koutsodontis George,Strati Areti,Kirodimos Efthymios,Giotakis Evangelos,Maragoudakis Pavlos,Prikas Constantine,Papadimitriou Nikolaos,Perisanidis Christos,Gagari Eleni,Kotsantis Ioannis,Vagia Elena,Anastasiou Maria,Gkotzamanidou Maria,Kavourakis George,Lianidou Evi^ORCID,Psyrri Amanda

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference62 articles.

1. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC collaborative group. Meta-analysis of chemotherapy on head and neck cancer;Pignon;Lancet,2000

2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients;Pignon;Radiother Oncol,2009

3. Radiotherapy and immunogenic cell death;Golden;Semin Radiat Oncol,2015

4. Abscopal, immunological effects of radiotherapy: narrowing the gap between clinical and preclinical experiences;Brix;Immunol Rev,2017

5. Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity;Lauber;Cancer Lett,2015

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role and clinical significance of immunogenic cell death biomarkers in chemoresistance and immunoregulation of head and neck squamous cell carcinoma;Biomedicine & Pharmacotherapy;2023-11

2. Identification of immunogenic cell death-related signature on prognosis and immunotherapy in kidney renal clear cell carcinoma;Frontiers in Immunology;2023-08-18

3. Clinical Significance of PD-L1 Status in Circulating Tumor Cells for Cancer Management during Immunotherapy;Biomedicines;2023-06-20

4. Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives;Biomarker Research;2022-12-07

5. Tumor-Promoting Activity and Proteomic Profiling of Cisplatin/Oxaliplatin-Derived DAMPs in Cholangiocarcinoma Cells;International Journal of Molecular Sciences;2022-09-11